New Herpes Zoster Subunit Vaccine Cost-Effective

The new two-dose, adjuvanted herpes zoster subunit vaccine, approved in 2017, is cost-effective when compared with the live attenuated vaccine or with no...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news